Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 190

1.

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 2.2019.

Gupta S, Provenzale D, Llor X, Halverson AL, Grady W, Chung DC, Haraldsdottir S, Markowitz AJ, Slavin TP Jr, Hampel H; CGC, Ness RM, Weiss JM, Ahnen DJ, Chen LM, Cooper G, Early DS, Giardiello FM, Hall MJ, Hamilton SR, Kanth P, Klapman JB, Lazenby AJ, Lynch PM, Mayer RJ, Mikkelson J; CGC, Peter S, Regenbogen SE, Dwyer MA; CGC, Ogba N.

J Natl Compr Canc Netw. 2019 Sep 1;17(9):1032-1041. doi: 10.6004/jnccn.2019.0044.

PMID:
31487681
2.

Folic acid supplementation and risk of colorectal neoplasia during long-term follow-up of a randomized clinical trial.

Passarelli MN, Barry EL, Rees JR, Mott LA, Zhang D, Ahnen DJ, Bresalier RS, Haile RW, McKeown-Eyssen G, Snover DC, Cole BF, Baron JA.

Am J Clin Nutr. 2019 Aug 10. pii: nqz160. doi: 10.1093/ajcn/nqz160. [Epub ahead of print]

PMID:
31401653
3.

Body Composition and Aspirin Dose for Colorectal Adenoma Prevention in a Randomized Clinical Trial.

Passarelli MN, Barry EL, Rees JR, Mott LA, Ahnen DJ, Baron JA.

Cancer Epidemiol Biomarkers Prev. 2019 Jul;28(7):1262-1265. doi: 10.1158/1055-9965.EPI-19-0205.

PMID:
31263057
4.

Ability of known susceptibility SNPs to predict colorectal cancer risk for persons with and without a family history.

Jenkins MA, Win AK, Dowty JG, MacInnis RJ, Makalic E, Schmidt DF, Dite GS, Kapuscinski M, Clendenning M, Rosty C, Winship IM, Emery JD, Saya S, Macrae FA, Ahnen DJ, Duggan D, Figueiredo JC, Lindor NM, Haile RW, Potter JD, Cotterchio M, Gallinger S, Newcomb PA, Buchanan DD, Casey G, Hopper JL.

Fam Cancer. 2019 Jun 17. doi: 10.1007/s10689-019-00136-6. [Epub ahead of print]

PMID:
31209717
5.

No Evidence for Posttreatment Effects of Vitamin D and Calcium Supplementation on Risk of Colorectal Adenomas in a Randomized Trial.

Calderwood AH, Baron JA, Mott LA, Ahnen DJ, Bostick RM, Figueiredo JC, Passarelli MN, Rees JR, Robertson DJ, Barry EL.

Cancer Prev Res (Phila). 2019 May;12(5):295-304. doi: 10.1158/1940-6207.CAPR-19-0023. Epub 2019 Mar 4.

PMID:
30833381
6.

Body mass index, calcium supplementation and risk of colorectal adenomas.

Barry EL, Lund JL, Westreich D, Mott LA, Ahnen DJ, Beck GJ, Bostick RM, Bresalier RS, Burke CA, Church TR, Rees JR, Robertson DJ, Baron JA.

Int J Cancer. 2019 Feb 1;144(3):448-458. doi: 10.1002/ijc.31803. Epub 2018 Oct 30.

PMID:
30117164
7.

NCCN Guidelines Insights: Colorectal Cancer Screening, Version 1.2018.

Provenzale D, Gupta S, Ahnen DJ, Markowitz AJ, Chung DC, Mayer RJ, Regenbogen SE, Blanco AM, Bray T, Cooper G, Early DS, Ford JM, Giardiello FM, Grady W, Hall MJ, Halverson AL, Hamilton SR, Hampel H, Klapman JB, Larson DW, Lazenby AJ, Llor X, Lynch PM, Mikkelson J, Ness RM, Slavin TP, Sugandha S, Weiss JM, Dwyer MA, Ogba N.

J Natl Compr Canc Netw. 2018 Aug;16(8):939-949. doi: 10.6004/jnccn.2018.0067.

PMID:
30099370
8.

Optimizing colorectal cancer screening by race and sex: Microsimulation analysis II to inform the American Cancer Society colorectal cancer screening guideline.

Meester RGS, Peterse EFP, Knudsen AB, de Weerdt AC, Chen JC, Lietz AP, Dwyer A, Ahnen DJ, Siegel RL, Smith RA, Zauber AG, Lansdorp-Vogelaar I.

Cancer. 2018 Jul 15;124(14):2974-2985. doi: 10.1002/cncr.31542. Epub 2018 May 30.

9.

The impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening: Microsimulation analysis I to inform the American Cancer Society colorectal cancer screening guideline.

Peterse EFP, Meester RGS, Siegel RL, Chen JC, Dwyer A, Ahnen DJ, Smith RA, Zauber AG, Lansdorp-Vogelaar I.

Cancer. 2018 Jul 15;124(14):2964-2973. doi: 10.1002/cncr.31543. Epub 2018 May 30.

10.

Colorectal Cancer in the Young.

Patel SG, Ahnen DJ.

Curr Gastroenterol Rep. 2018 Mar 28;20(4):15. doi: 10.1007/s11894-018-0618-9. Review.

PMID:
29616330
11.

Our New President-David A. Lieberman, MD, AGAF, FACG.

Ahnen DJ.

Gastroenterology. 2018 May;154(6):1836-1842.e7. doi: 10.1053/j.gastro.2018.03.046. Epub 2018 Mar 30. No abstract available.

PMID:
29605171
12.

Calcium and vitamin D supplementation and increased risk of serrated polyps: results from a randomised clinical trial.

Crockett SD, Barry EL, Mott LA, Ahnen DJ, Robertson DJ, Anderson JC, Wallace K, Burke CA, Bresalier RS, Figueiredo JC, Snover DC, Baron JA.

Gut. 2018 Mar 1. pii: gutjnl-2017-315242. doi: 10.1136/gutjnl-2017-315242. [Epub ahead of print]

13.

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 3.2017.

Gupta S, Provenzale D, Regenbogen SE, Hampel H, Slavin TP, Hall MJ, Llor X, Chung DC, Ahnen DJ, Bray T, Cooper G, Early DS, Ford JM, Giardiello FM, Grady W, Halverson AL, Hamilton SR, Klapman JB, Larson DW, Lazenby AJ, Lynch PM, Markowitz AJ, Mayer RJ, Ness RM, Samadder NJ, Shike M, Sugandha S, Weiss JM, Dwyer MA, Ogba N.

J Natl Compr Canc Netw. 2017 Dec;15(12):1465-1475. doi: 10.6004/jnccn.2017.0176.

PMID:
29223984
14.

Colonoscopy vs. Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM): Rationale for Study Design.

Dominitz JA, Robertson DJ, Ahnen DJ, Allison JE, Antonelli M, Boardman KD, Ciarleglio M, Del Curto BJ, Huang GD, Imperiale TF, Larson MF, Lieberman D, O'Connor T, O'Leary TJ, Peduzzi P, Provenzale D, Shaukat A, Sultan S, Voorhees A, Wallace R, Guarino PD.

Am J Gastroenterol. 2017 Nov;112(11):1736-1746. doi: 10.1038/ajg.2017.286. Epub 2017 Oct 10.

PMID:
29016565
15.

Can the Sum of Adenoma Diameters (Adenoma Bulk) on Index Examination Predict Risk of Metachronous Advanced Neoplasia?

Anderson JC, Morris CB, Robertson DJ, Barry ELR, Figueiredo JC, Cruz-Correa M, Bostick RM, Ahnen DJ, Baron JA.

J Clin Gastroenterol. 2018 Aug;52(7):628-634. doi: 10.1097/MCG.0000000000000899.

16.

Timing of Aspirin and Other Nonsteroidal Anti-Inflammatory Drug Use Among Patients With Colorectal Cancer in Relation to Tumor Markers and Survival.

Hua X, Phipps AI, Burnett-Hartman AN, Adams SV, Hardikar S, Cohen SA, Kocarnik JM, Ahnen DJ, Lindor NM, Baron JA, Newcomb PA.

J Clin Oncol. 2017 Aug 20;35(24):2806-2813. doi: 10.1200/JCO.2017.72.3569. Epub 2017 Jun 15.

17.

Colorectal cancer statistics, 2017.

Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RGS, Barzi A, Jemal A.

CA Cancer J Clin. 2017 May 6;67(3):177-193. doi: 10.3322/caac.21395. Epub 2017 Mar 1.

18.

Factors Associated With Shorter Colonoscopy Surveillance Intervals for Patients With Low-Risk Colorectal Adenomas and Effects on Outcome.

Anderson JC, Baron JA, Ahnen DJ, Barry EL, Bostick RM, Burke CA, Bresalier RS, Church TR, Cole BF, Cruz-Correa M, Kim AS, Mott LA, Sandler RS, Robertson DJ.

Gastroenterology. 2017 Jun;152(8):1933-1943.e5. doi: 10.1053/j.gastro.2017.02.010. Epub 2017 Feb 20.

19.

Plasma lipoxin A4 and resolvin D1 are not associated with reduced adenoma risk in a randomized trial of aspirin to prevent colon adenomas.

Fedirko V, McKeown-Eyssen G, Serhan CN, Barry EL, Sandler RS, Figueiredo JC, Ahnen DJ, Bresalier RS, Robertson DJ, Anderson CW, Baron JA.

Mol Carcinog. 2017 Aug;56(8):1977-1983. doi: 10.1002/mc.22629. Epub 2017 Mar 6.

20.

APC-Associated Polyposis Conditions.

Jasperson KW, Patel SG, Ahnen DJ.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019.
1998 Dec 18 [updated 2017 Feb 2].

21.

Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer.

Win AK, Jenkins MA, Dowty JG, Antoniou AC, Lee A, Giles GG, Buchanan DD, Clendenning M, Rosty C, Ahnen DJ, Thibodeau SN, Casey G, Gallinger S, Le Marchand L, Haile RW, Potter JD, Zheng Y, Lindor NM, Newcomb PA, Hopper JL, MacInnis RJ.

Cancer Epidemiol Biomarkers Prev. 2017 Mar;26(3):404-412. doi: 10.1158/1055-9965.EPI-16-0693. Epub 2016 Oct 31.

22.

Regarding "Colorectal Cancer Screening Quality Measures: Beyond Colonoscopy".

Ahnen DJ, Schroy PC 3rd, Weber TK.

Clin Gastroenterol Hepatol. 2016 Nov;14(11):1668-1669. doi: 10.1016/j.cgh.2016.05.037. Epub 2016 Jun 3. No abstract available.

PMID:
27266981
23.

Shifts in the Fecal Microbiota Associated with Adenomatous Polyps.

Hale VL, Chen J, Johnson S, Harrington SC, Yab TC, Smyrk TC, Nelson H, Boardman LA, Druliner BR, Levin TR, Rex DK, Ahnen DJ, Lance P, Ahlquist DA, Chia N.

Cancer Epidemiol Biomarkers Prev. 2017 Jan;26(1):85-94. doi: 10.1158/1055-9965.EPI-16-0337. Epub 2016 Sep 26.

24.

Colorectal Cancer: Genetics is Changing Everything.

Obuch JC, Ahnen DJ.

Gastroenterol Clin North Am. 2016 Sep;45(3):459-76. doi: 10.1016/j.gtc.2016.04.005. Review.

PMID:
27546843
25.

Selenium Supplementation for Prevention of Colorectal Adenomas and Risk of Associated Type 2 Diabetes.

Thompson PA, Ashbeck EL, Roe DJ, Fales L, Buckmeier J, Wang F, Bhattacharyya A, Hsu CH, Chow HH, Ahnen DJ, Boland CR, Heigh RI, Fay DE, Hamilton SR, Jacobs ET, Martinez ME, Alberts DS, Lance P.

J Natl Cancer Inst. 2016 Aug 16;108(12). pii: djw152. doi: 10.1093/jnci/djw152. Print 2016 Dec.

26.

Celecoxib for the Prevention of Colorectal Adenomas: Results of a Suspended Randomized Controlled Trial.

Thompson PA, Ashbeck EL, Roe DJ, Fales L, Buckmeier J, Wang F, Bhattacharyya A, Hsu CH, Chow SH, Ahnen DJ, Boland CR, Heigh RI, Fay DE, Hamilton SR, Jacobs ET, Martinez EM, Alberts DS, Lance P.

J Natl Cancer Inst. 2016 Aug 16;108(12). pii: djw151. doi: 10.1093/jnci/djw151. Print 2016 Dec.

27.

Genetic/Familial High-Risk Assessment: Colorectal Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.

Provenzale D, Gupta S, Ahnen DJ, Bray T, Cannon JA, Cooper G, David DS, Early DS, Erwin D, Ford JM, Giardiello FM, Grady W, Halverson AL, Hamilton SR, Hampel H, Ismail MK, Klapman JB, Larson DW, Lazenby AJ, Lynch PM, Mayer RJ, Ness RM, Regenbogen SE, Samadder NJ, Shike M, Steinbach G, Weinberg D, Dwyer M, Darlow S.

J Natl Compr Canc Netw. 2016 Aug;14(8):1010-30.

PMID:
27496117
28.

Risk factors for metachronous colorectal cancer or polyp: A systematic review and meta-analysis.

Jayasekara H, Reece JC, Buchanan DD, Ahnen DJ, Parry S, Jenkins MA, Win AK.

J Gastroenterol Hepatol. 2017 Feb;32(2):301-326. doi: 10.1111/jgh.13476. Review.

PMID:
27356122
29.

Understanding the contribution of family history to colorectal cancer risk and its clinical implications: A state-of-the-science review.

Lowery JT, Ahnen DJ, Schroy PC 3rd, Hampel H, Baxter N, Boland CR, Burt RW, Butterly L, Doerr M, Doroshenk M, Feero WG, Henrikson N, Ladabaum U, Lieberman D, McFarland EG, Peterson SK, Raymond M, Samadder NJ, Syngal S, Weber TK, Zauber AG, Smith R.

Cancer. 2016 Sep 1;122(17):2633-45. doi: 10.1002/cncr.30080. Epub 2016 Jun 3. Review. Erratum in: Cancer. 2017 Oct 1;123(19):3857.

30.

Risk factors for metachronous colorectal cancer following a primary colorectal cancer: A prospective cohort study.

Jayasekara H, Reece JC, Buchanan DD, Rosty C, Dashti SG, Ait Ouakrim D, Winship IM, Macrae FA, Boussioutas A, Giles GG, Ahnen DJ, Lowery J, Casey G, Haile RW, Gallinger S, Le Marchand L, Newcomb PA, Lindor NM, Hopper JL, Parry S, Jenkins MA, Win AK.

Int J Cancer. 2016 Sep 1;139(5):1081-90. doi: 10.1002/ijc.30153. Epub 2016 May 9.

31.

Chemoprevention of hereditary colon cancers: time for new strategies.

Ricciardiello L, Ahnen DJ, Lynch PM.

Nat Rev Gastroenterol Hepatol. 2016 Jun;13(6):352-61. doi: 10.1038/nrgastro.2016.56. Epub 2016 Apr 20. Review.

PMID:
27095653
32.

Multivitamin, calcium and folic acid supplements and the risk of colorectal cancer in Lynch syndrome.

Chau R, Dashti SG, Ait Ouakrim D, Buchanan DD, Clendenning M, Rosty C, Winship IM, Young JP, Giles GG, Macrae FA, Boussioutas A, Parry S, Figueiredo JC, Levine AJ, Ahnen DJ, Casey G, Haile RW, Gallinger S, Le Marchand L, Thibodeau SN, Lindor NM, Newcomb PA, Potter JD, Baron JA, Hopper JL, Jenkins MA, Win AK.

Int J Epidemiol. 2016 Jun;45(3):940-53. doi: 10.1093/ije/dyw036. Epub 2016 Apr 10.

33.

Association between adenoma location and risk of recurrence.

Pohl H, Robertson DJ, Mott LA, Ahnen DJ, Burke CA, Barry EL, Bresalier RS, Figueiredo JC, Shaukat A, Sandler RS, Baron JA.

Gastrointest Endosc. 2016 Oct;84(4):709-16. doi: 10.1016/j.gie.2016.02.048. Epub 2016 Mar 11.

34.

Knowledge and Uptake of Genetic Counseling and Colonoscopic Screening Among Individuals at Increased Risk for Lynch Syndrome and their Endoscopists from the Family Health Promotion Project.

Patel SG, Ahnen DJ, Kinney AY, Horick N, Finkelstein DM, Hill DA, Lindor NM, MaCrae F, Lowery JT.

Am J Gastroenterol. 2016 Feb;111(2):285-93. doi: 10.1038/ajg.2015.397. Epub 2016 Feb 9.

35.

Real-Time Characterization of Diminutive Colorectal Polyp Histology Using Narrow-Band Imaging: Implications for the Resect and Discard Strategy.

Patel SG, Schoenfeld P, Kim HM, Ward EK, Bansal A, Kim Y, Hosford L, Myers A, Foster S, Craft J, Shopinski S, Wilson RH, Ahnen DJ, Rastogi A, Wani S.

Gastroenterology. 2016 Feb;150(2):406-18. doi: 10.1053/j.gastro.2015.10.042. Epub 2015 Oct 30.

36.

Clinicopathologic Risk Factor Distributions for MLH1 Promoter Region Methylation in CIMP-Positive Tumors.

Levine AJ, Phipps AI, Baron JA, Buchanan DD, Ahnen DJ, Cohen SA, Lindor NM, Newcomb PA, Rosty C, Haile RW, Laird PW, Weisenberger DJ.

Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):68-75. doi: 10.1158/1055-9965.EPI-15-0935. Epub 2015 Oct 28.

37.

A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas.

Baron JA, Barry EL, Mott LA, Rees JR, Sandler RS, Snover DC, Bostick RM, Ivanova A, Cole BF, Ahnen DJ, Beck GJ, Bresalier RS, Burke CA, Church TR, Cruz-Correa M, Figueiredo JC, Goodman M, Kim AS, Robertson DJ, Rothstein R, Shaukat A, Seabrook ME, Summers RW.

N Engl J Med. 2015 Oct 15;373(16):1519-30. doi: 10.1056/NEJMoa1500409.

38.

Risk Factors for Hemorrhoids on Screening Colonoscopy.

Peery AF, Sandler RS, Galanko JA, Bresalier RS, Figueiredo JC, Ahnen DJ, Barry EL, Baron JA.

PLoS One. 2015 Sep 25;10(9):e0139100. doi: 10.1371/journal.pone.0139100. eCollection 2015.

39.

Urinary metabolites of prostanoids and risk of recurrent colorectal adenomas in the Aspirin/Folate Polyp Prevention Study (AFPPS).

Fedirko V, Bradshaw PT, Figueiredo JC, Sandler RS, Barry EL, Ahnen DJ, Milne GL, Bresalier RS, Baron JA.

Cancer Prev Res (Phila). 2015 Nov;8(11):1061-8. doi: 10.1158/1940-6207.CAPR-15-0212. Epub 2015 Aug 24.

40.

Colorectal Cancer Screening, Version 1.2015.

Provenzale D, Jasperson K, Ahnen DJ, Aslanian H, Bray T, Cannon JA, David DS, Early DS, Erwin D, Ford JM, Giardiello FM, Gupta S, Halverson AL, Hamilton SR, Hampel H, Ismail MK, Klapman JB, Larson DW, Lazenby AJ, Lynch PM, Mayer RJ, Ness RM, Rao MS, Regenbogen SE, Shike M, Steinbach G, Weinberg D, Dwyer MA, Freedman-Cass DA, Darlow S; National comprehensive cancer netwok.

J Natl Compr Canc Netw. 2015 Aug;13(8):959-68; quiz 968.

PMID:
26285241
41.

Female Hormonal Factors and the Risk of Endometrial Cancer in Lynch Syndrome.

Dashti SG, Chau R, Ouakrim DA, Buchanan DD, Clendenning M, Young JP, Winship IM, Arnold J, Ahnen DJ, Haile RW, Casey G, Gallinger S, Thibodeau SN, Lindor NM, Le Marchand L, Newcomb PA, Potter JD, Baron JA, Hopper JL, Jenkins MA, Win AK.

JAMA. 2015 Jul 7;314(1):61-71. doi: 10.1001/jama.2015.6789.

42.

Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome.

Ait Ouakrim D, Dashti SG, Chau R, Buchanan DD, Clendenning M, Rosty C, Winship IM, Young JP, Giles GG, Leggett B, Macrae FA, Ahnen DJ, Casey G, Gallinger S, Haile RW, Le Marchand L, Thibodeau SN, Lindor NM, Newcomb PA, Potter JD, Baron JA, Hopper JL, Jenkins MA, Win AK.

J Natl Cancer Inst. 2015 Jun 24;107(9). pii: djv170. doi: 10.1093/jnci/djv170. Print 2015 Sep.

43.

Association between body mass index and mortality for colorectal cancer survivors: overall and by tumor molecular phenotype.

Campbell PT, Newton CC, Newcomb PA, Phipps AI, Ahnen DJ, Baron JA, Buchanan DD, Casey G, Cleary SP, Cotterchio M, Farris AB, Figueiredo JC, Gallinger S, Green RC, Haile RW, Hopper JL, Jenkins MA, Le Marchand L, Makar KW, McLaughlin JR, Potter JD, Renehan AG, Sinicrope FA, Thibodeau SN, Ulrich CM, Win AK, Lindor NM, Limburg PJ.

Cancer Epidemiol Biomarkers Prev. 2015 Aug;24(8):1229-38. doi: 10.1158/1055-9965.EPI-15-0094. Epub 2015 Jun 2.

44.

PIK3CA Somatic Mutation Status in Relation to Patient and Tumor Factors in Racial/Ethnic Minorities with Colorectal Cancer.

Phipps AI, Ahnen DJ, Cheng I, Newcomb PA, Win AK, Burnett T.

Cancer Epidemiol Biomarkers Prev. 2015 Jul;24(7):1046-51. doi: 10.1158/1055-9965.EPI-15-0204. Epub 2015 May 20.

45.

CRC screening, past, present, and future: a tribute to Emmet Keeffe.

Ahnen DJ, Bresalier RS, Levin B, Kaunitz JD.

Dig Dis Sci. 2015 Mar;60(3):589-91. doi: 10.1007/s10620-015-3603-2. No abstract available.

46.

Practical opportunities to improve early detection and prevention of colorectal cancer (CRC) in members of high-risk families.

Patel SG, Lowery JT, Gatof D, Ahnen DJ.

Dig Dis Sci. 2015 Mar;60(3):748-61. doi: 10.1007/s10620-015-3567-2. Epub 2015 Feb 20. Review.

PMID:
25698379
47.

Sessile serrated polyps: detection, eradication, and prevention of the evil twin.

Obuch JC, Pigott CM, Ahnen DJ.

Curr Treat Options Gastroenterol. 2015 Mar;13(1):156-70. doi: 10.1007/s11938-015-0046-y.

48.

Association of the colorectal CpG island methylator phenotype with molecular features, risk factors, and family history.

Weisenberger DJ, Levine AJ, Long TI, Buchanan DD, Walters R, Clendenning M, Rosty C, Joshi AD, Stern MC, LeMarchand L, Lindor NM, Daftary D, Gallinger S, Selander T, Bapat B, Newcomb PA, Campbell PT, Casey G, Ahnen DJ, Baron JA, Haile RW, Hopper JL, Young JP, Laird PW, Siegmund KD; Colon Cancer Family Registry.

Cancer Epidemiol Biomarkers Prev. 2015 Mar;24(3):512-519. doi: 10.1158/1055-9965.EPI-14-1161. Epub 2015 Jan 13.

49.

Colon cancer screening for Colorado's underserved: a community clinic/academic partnership.

Wolf HJ, Dwyer A, Ahnen DJ, Pray SL, Rein SM, Morwood KD, Lowery JT, Masias A, Collins NJ, Brown CE, DeMaio Goheen CA, McAbee KE, Sauaia A, Byers TE.

Am J Prev Med. 2015 Mar;48(3):264-70. doi: 10.1016/j.amepre.2014.09.016. Epub 2014 Dec 26.

PMID:
25547926
50.

Smoking-associated risks of conventional adenomas and serrated polyps in the colorectum.

Figueiredo JC, Crockett SD, Snover DC, Morris CB, McKeown-Eyssen G, Sandler RS, Ahnen DJ, Robertson DJ, Burke CA, Bresalier RS, Church JM, Church TR, Baron JA.

Cancer Causes Control. 2015 Mar;26(3):377-86. doi: 10.1007/s10552-014-0513-0. Epub 2014 Dec 24.

Supplemental Content

Loading ...
Support Center